SLDB - Solid Biosciences

...

Available for logged in users only.

The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.

• Solid Biosciences files to sell 19.69M common shares for holders
• Solid Biosciences wins FDA orphan status for gene therapy (update)
• Solid Biosciences raises $109M through private placement
• Solid Biosciences receives FDA Fast Track designation for Duchenne gene therapy candidate
• Solid Biosciences gets FDA okay for clinical testing of DMD gene therapy
• Solid Biosciences reports Q3 results
• Solid Bio draws new Overweight rating at Cantor on valuation
• Solid Biosciences reports Q2 results
• Solid Biosciences reports Q1 results
• Solid Biosciences reports Q4 results
• Solid Biosciences, Phlox team up to develop precision drugs for heart diseases
• Kevin Tan is the new finance chief at Solid Biosciences
• Solid Biosciences announces stockholder approval of acquisition of AavantiBio
• Solid Biosciences reports Q3 results
• Solid Biosciences announces 1-for-15 reverse stock split
• Solid Bio adds 14% as JPMorgan upgrades on AavantiBio buyout
• Solid Biosciences to acquire gene therapy company AavantiBio
• Solid Biosciences to acquire gene therapy company AavantiBio
• Solid Biosciences reports Q2 results
• Catalyst watch: Levi Strauss earnings, Ford sales and travel stocks put to the test